Comparison of Alternative Claims-Based Operational Definitions for Cancer Control Indicators Using Nationwide Claims Data in Japan
Annals of Clinical Epidemiology · 2026
DOI: 10.37737/ace.27020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical Epidemiology, 2026. Verfasst von Yoko Nakazawa und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Background:Japan’s National Database of Health Insurance Claims (NDB) is used as a data source for selected national cancer control indicators. However, national policy does not explicitly define “patients with cancer” for claims-based measurement. We quantified variations in NDB-based cancer control indicator values across diagnosis-code restrictions.Methods:We conducted a repeated cross-sectional study using NDB data from fiscal years (FY) 2020–2022. We assessed 11 indicators using an unrestricted comparator, two all-cancer definitions requiring either any confirmed cancer diagnosis or a principal cancer diagnosis, and a six-site sensitivity analysis. Procedure counts were compared, and retained proportions were calculated relative to the unrestricted algorithm.Results:The algorithm requiring any confirmed cancer diagnosis retained 99.2% and 99.1% of procedure counts for cancer-specific indicators, as expected because a cancer diagnosis was required for reimbursement, and 95.1%–97.5% for cancer-predominant indicators. The principal-diagnosis definition and six-site sensitivity analysis retained 71.6%–74.6% and 61.6%–64.5%, respectively, for cancer-specific indicators. For indicators based on procedure codes not specific to cancer care, the algorithm requiring any confirmed cancer diagnosis retained 21.1%–88.4% of unrestricted procedure counts, representing the proportions that met the cancer-diagnosis restriction.Conclusions:NDB-based cancer control indicator values varied substantially according to the case-identification algorithm. Among the approaches examined, requiring any confirmed cancer diagnosis was selected post hoc as a reasonable default for national monitoring of these 11 indicators because it avoids reliance on principal-diagnosis coding practices and remains applicable across cancer sites. This pragmatic choice should not be interpreted as evidence of diagnostic accuracy.
Zitieren
APA
Nakazawa, Y., Takahashi, R., Okumura, Y., Ogawa, A., Sawada, N., Matsuoka, Y., & Inoue, M. (2026). Comparison of Alternative Claims-Based Operational Definitions for Cancer Control Indicators Using Nationwide Claims Data in Japan. Annals of Clinical Epidemiology. https://doi.org/10.37737/ace.27020
Vancouver
Nakazawa Y, Takahashi R, Okumura Y, Ogawa A, Sawada N, Matsuoka Y, et al. Comparison of Alternative Claims-Based Operational Definitions for Cancer Control Indicators Using Nationwide Claims Data in Japan. Annals of Clinical Epidemiology. 2026. doi:10.37737/ace.27020
BibTeX
@article{Nakazawa2026,
author = {Nakazawa, Yoko and Takahashi, Richi and Okumura, Yasuyuki and Ogawa, Asao and Sawada, Norie and Matsuoka, Yutaka and Inoue, Manami},
title = {Comparison of Alternative Claims-Based Operational Definitions for Cancer Control Indicators Using Nationwide Claims Data in Japan},
journal = {Annals of Clinical Epidemiology},
year = {2026},
doi = {10.37737/ace.27020}
}
EUVIMED